Video

Understanding the Role of the COVID-19 Pandemic in Increased Substance Use Disorder: Opportunities for Pharmacist Intervention

An expert panel led by moderator Dr. Cunningham identify substance use disorder, COVID-19’s role, and opportunities for pharmacists to help patients with resources for recovery.

Please see PDF above for article related to this video.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
5 experts in this video
1 expert is featured in this series.
5 experts in this video
5 experts in this video
1 expert is featured in this series.
1 expert is featured in this series.
5 experts in this video
5 experts in this video
1 expert is featured in this series.
1 expert is featured in this series.
Related Content
HOPA 2025: Understanding the Recent Changes for 505(b)(2) Drugs and Reimbursement
April 12th 2025

HOPA 2025: Understanding the Recent Changes for 505(b)(2) Drugs and Reimbursement

Alana Hippensteele, Lead Editor
Pharmacy Focus: Oncology Edition
April 17th 2023

Pharmacy Focus: Oncology Edition - Consider Treatment Sequences Carefully in Myeloma

Navigating Prescription Stimulant Use: Safety, Legal, and Supply Challenges in Pharmacy Practice
January 10th 2025

Navigating Prescription Stimulant Use: Safety, Legal, and Supply Challenges in Pharmacy Practice

Elise Moore, PharmD Candidate Katie Bye, PharmD Megan Leloux, PharmD, BCPP
Eculizumab and Other Therapies for the Treatment of High-Risk Transplant-Associated Thrombotic Microangiopathy
October 3rd 2024

Eculizumab and Other Therapies for the Treatment of High-Risk Transplant-Associated Thrombotic Microangiopathy

Hayden Mitteer, PharmD Candidate
So-Called “Ozempic Babies” Raise Questions About Unintended Effects of GLP-1 Agonists
October 3rd 2024

So-Called “Ozempic Babies” Raise Questions About Unintended Effects of GLP-1 Agonists

Alejandra C. Nogueira, PharmD Candidate
AHA Statement Reviews Benefits, Risks of Alternative Therapies for Heart Failure
October 1st 2024

AHA Statement Reviews Benefits, Risks of Alternative Therapies for Heart Failure

Jennifer N. Tovar, PharmD Candidate